As of 2024-12-13, the Intrinsic Value of 9 Meters Biopharma Inc (NMTR) is
-9.35 USD. This NMTR valuation is based on the model Peter Lynch Fair Value.
With the current market price of 0.07 USD, the upside of 9 Meters Biopharma Inc is
-13,054.50%.
Note: result may not be accurate due to the invalid valuation result of Peter Lynch's fair value model.
-9.35 USD
Intrinsic Value
NMTR Intrinsic Value - Valuation Summary
|
Range |
Selected |
Upside |
| a |
| Fair Value |
-9.35 - -9.35 |
-9.35 |
-13,054.50% |
| P/E |
(52.00) - (55.33) |
(55.46) |
-76920.3% |
| DDM - Stable |
(13.31) - (43.60) |
(28.46) |
-39514.0% |
| DDM - Multi |
(11.12) - (29.81) |
(16.38) |
-22782.8% |
NMTR Intrinsic Value - Key Valuation Metrics
| Market Cap (mil) |
1.04 |
| Beta |
1.47 |
| Outstanding shares (mil) |
14.46 |
| Enterprise Value (mil) |
-0.82 |
| Market risk premium |
5.00% |
| Cost of Equity |
10.85% |
| Cost of Debt |
5.00% |
| WACC |
5.44% |